Hsp27 as a Therapeutic Target in Cancers

Author(s): Julie Acunzo , Claudia Andrieu , Virginie Baylot , Alan So , Palma Rocchi .

Journal Name: Current Drug Targets

Volume 15 , Issue 4 , 2014

Become EABM
Become Reviewer


Heat shock protein 27 (Hsp27), induced by heat shock, environmental and pathophysiological stressors, is a multidimensional protein that acts as a protein chaperone and an antioxidant. This protein plays a major role in the inhibition of apoptosis and actin cytoskeletal remodeling. This stress-activated protein is up-regulated in many cancers and is associated with poor prognosis as well as treatment resistance by protecting cells from therapeutic agent that normally induces apoptosis. This review highlights the most recent findings and role of Hsp27 in cancer and the different strategies to target and inhibit Hsp27 for clinical purposes.

Keywords: Cancer, heat shock protein Hsp27, protein inhibition, targeted therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [423 - 431]
Pages: 9
DOI: 10.2174/13894501113146660230
Price: $58

Article Metrics

PDF: 49